- Source: Janagliflozin
Janagliflozin is an SGLT2 inhibitor developed by Sihuan Pharmaceutical. It is approved in China for the treatment of type 2 diabetes.
References
Kata Kunci Pencarian:
- Janagliflozin
- Dapagliflozin
- Empagliflozin
- Henagliflozin
- Enavogliflozin
- SGLT2 inhibitor
- Glucose transporter
- Canagliflozin
- Dapagliflozin/sitagliptin
- Sodium-glucose transport proteins
